Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a walking program ease chronic pain? new study tests feasibility

NCT ID NCT05700383

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 10-week mind-body walking program (GetActive-Fitbit) is feasible for adults with chronic musculoskeletal pain. 92 participants were randomly assigned to either the walking program or a health education group. The goal was to see if people would join, stick with it, and find it helpful, paving the way for a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
GetActive-Fitbit program (behavioral intervention: mind-body skills, walking, and cognitive techniques)
What this could lead to
If successful, this could lead to a larger trial that may confirm a low-cost, non-drug program to help people with chronic pain move better and feel better.
What could go wrong
This is a small feasibility study (92 participants) testing only whether the program can be delivered and accepted, not whether it works. Results may not apply to all pain types or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

92 people

The number who actually took part.

Started

Apr 2023

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male and female outpatients, age 18 years or older 2. Fluent in English 3. Have nonmalignant chronic musculoskeletal pain for more than 3 months 4. Able to perform a 6-minute walk test (6MWT) 5. Owns a smartphone with Bluetooth 4.0 or computer 6. Willingness and ability to participate in one of the 2 programs and to comply with the requirements of the study protocol. 7. Free of concurrent psychotropic medication for at least 2 weeks prior to initiation of treatment, OR stable on current medication for a minimum of 6 weeks and willing to maintain a stable dose 8. Low-level of activity (must meet 2/3 criteria; if difficult to assess, recruiter may ask participant to report their recent step data from their smartphone to better understand their activity level) 1. Sitting for more than 8 hours/day per self-report 2. Exercising for fewer than 3 days/week (30+min of exercise constitutes an "exercise day") per self-report 3. Walking for fewer than 7 days/week (30+min of walking constitutes a "walking day") per self-report Exclusion Criteria: 1. Diagnosed with a medical illness expected to worsen in the next 6 months (e.g., malignancy) 2. Serious mental illness or instability for which hospitalization may be likely in the next 6 months 3. Current active suicidal ideation reported on self-report 4. Untreated and/or unstable schizophrenia, bipolar disorder, or other psychotic disorder 5. Current, active substance abuse or dependence, and current alcohol dependence within the past 6 months 6. Practice of yoga, meditation, guided imagery or other mind body techniques that elicit the RR, once per week for \>45 min 3 times/week within the last 3 months or less. 7. Regular use of Fitbit DMD in the last 3 months 8. Unable to walk/in a wheelchair 9. Mild cognitive decline for participants 65+ only (Short Portable Mental Status Questionnaire; PMSQ 4 or more errors).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Duke University

    Durham, North Carolina, 27705, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Rush Medical Center

    Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.